ARCHIVES

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

This article is from The Cancer Letter archive.

Vol. 09 No. 40 | October 21, 1983

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001

Carbone Heads Chairmen’s Group

June 30, 1978

NCI Communications Office to contract Media Campaigns

October 22, 1993